Published in J Nucl Med on May 01, 1992
Characterization of scatter and penetration using Monte Carlo simulation in 131I imaging. J Nucl Med (2000) 1.24
Accuracy of 131I tumor quantification in radioimmunotherapy using SPECT imaging with an ultra-high-energy collimator: Monte Carlo study. J Nucl Med (2000) 1.09
A parallel Monte Carlo code for planar and SPECT imaging: implementation, verification and applications in (131)I SPECT. Comput Methods Programs Biomed (2002) 0.90
Depth of interaction decoding of a continuous crystal detector module. Phys Med Biol (2007) 9.45
New Directions for dMiCE - a Depth-of-Interaction Detector Design for PET Scanners. IEEE Nucl Sci Symp Conf Rec (1997) (2007) 3.94
Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl J Med (1993) 3.18
Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole. Int J Radiat Oncol Biol Phys (1992) 2.61
Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? AJNR Am J Neuroradiol (1998) 2.21
Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. Int J Radiat Oncol Biol Phys (1996) 2.12
A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas. Blood (2000) 2.11
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res (2000) 1.89
Performance standards in positron emission tomography. J Nucl Med (1991) 1.78
Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas. Lancet (1995) 1.69
Imaging and treatment of B-cell lymphoma. J Nucl Med (1990) 1.68
Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children's Oncology Group Bone Tumor Committee. Pediatr Blood Cancer (2008) 1.66
[(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur J Nucl Med Mol Imaging (2003) 1.62
Samarium-153-EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I/II trial. J Nucl Med (1993) 1.55
Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol (1989) 1.43
An 8×8 Row-Column Summing Readout Electronics for Preclinical Positron Emission Tomography Scanners. IEEE Nucl Sci Symp Conf Rec (1997) (2009) 1.41
18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast cancer. J Clin Oncol (2001) 1.35
Phase I study of (131)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome. Blood (1999) 1.31
Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int J Radiat Oncol Biol Phys (1995) 1.29
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemia. Transplantation (1992) 1.25
Internal mammary lymph node drainage patterns in patients with breast cancer documented by breast lymphoscintigraphy. Ann Surg Oncol (2001) 1.18
Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue. J Clin Oncol (1998) 1.13
Duration of occupancy of opiate receptors by naltrexone. J Nucl Med (1988) 1.12
The use of importance sampling techniques to improve the efficiency of photon tracking in emission tomography simulations. Med Phys (1992) 1.12
Glucose metabolism in human malignant gliomas measured quantitatively with PET, 1-[C-11]glucose and FDG: analysis of the FDG lumped constant. J Nucl Med (1998) 1.09
Increased false negative sentinel node biopsy rates after preoperative chemotherapy for invasive breast carcinoma. Cancer (2000) 1.06
Kinetic analysis of 2-[carbon-11]thymidine PET imaging studies: compartmental model and mathematical analysis. J Nucl Med (1998) 1.05
Measured count-rate performance of the Discovery STE PET/CT scanner in 2D, 3D and partial collimation acquisition modes. Phys Med Biol (2008) 1.03
Localization of radiolabeled antimyeloid antibodies in a human acute leukemia xenograft tumor model. Cancer Res (1992) 1.01
Carbon-11-thymidine and FDG to measure therapy response. J Nucl Med (1998) 0.98
Imaging cellular proliferation as a measure of response to therapy. J Clin Pharmacol (2001) 0.97
Effective count rates for PET scanners with reduced and extended axial field of view. Phys Med Biol (2011) 0.97
Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy. AJR Am J Roentgenol (1998) 0.97
Evaluation of a clinical scintillation camera with pulse tail extrapolation electronics. J Nucl Med (1989) 0.93
Parametric positioning of a continuous crystal PET detector with depth of interaction decoding. Phys Med Biol (2008) 0.93
Radiolabeled anti-CD45 monoclonal antibodies target lymphohematopoietic tissue in the macaque. Blood (1991) 0.92
Skeletal nonvisualization in a bone scan secondary to intravenous etidronate therapy. J Nucl Med (1992) 0.90
Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography. J Nucl Med (1992) 0.89
Quantitative autoradiography using a personal computer. J Nucl Med (1986) 0.89
Quantitative autoradiographic evidence for insulin receptors in the choroid plexus of the rat brain. Diabetes (1986) 0.86
FPGA-Based Pulse Pileup Correction. IEEE Nucl Sci Symp Conf Rec (1997) (2010) 0.86
Immunoreactivity assay for labeled anti-melanoma monoclonal antibodies. J Nucl Med (1986) 0.86
Analysis of blood clearance and labeled metabolites for the estrogen receptor tracer [F-18]-16 alpha-fluoroestradiol (FES). Nucl Med Biol (1997) 0.85
Energy-based scatter corrections for scintillation camera images of iodine-131. J Nucl Med (1996) 0.85
A statistical modeling approach to the analysis of spatial patterns of FDG-PET uptake in human sarcoma. IEEE Trans Med Imaging (2011) 0.84
Vascular response to radiation injury in the rat lung. Radiat Res (1992) 0.84
Kinetic analysis of 2-[11C]thymidine PET imaging studies: validation studies. J Nucl Med (1999) 0.84
Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma. J Nucl Med (1987) 0.83
Multiwindow scatter correction techniques in single-photon imaging. Med Phys (1995) 0.83
Total body calcium by neutron activation analysis in normals and osteoporotic populations: a discriminator of significant bone mass loss. J Lab Clin Med (1983) 0.83
Blood flow changes following 137Cs irradiation in a rat glioma model. Radiat Res (1988) 0.82
Post therapy imaging in high dose I-131 radioimmunotherapy patients. Med Phys (1994) 0.82
High-dose radioimmunotherapy of B cell lymphomas. Front Radiat Ther Oncol (1990) 0.80
Identification of interleukin-2-induced complete response in metastatic renal cell carcinoma by FDG PET despite radiographic evidence suggesting persistent tumor. AJR Am J Roentgenol (1997) 0.79
Quantification of iodine-131 distribution by gamma camera imaging. Eur J Nucl Med (1991) 0.78
Indium-111 white blood cell scan for infectious complications of polycystic renal disease. J Nucl Med (1985) 0.78
Evaluation of event position reconstruction in monolithic crystals that are optically coupled. Phys Med Biol (2016) 0.78
Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets. Blood (1995) 0.78
Comparison of transaxial resolution in 180 degrees and 360 degrees SPECT with a rotating scintillation camera. Eur J Nucl Med (1987) 0.78
Improving the tumor retention of radioiodinated antibody: aryl carbohydrate adducts. Cancer Res (1990) 0.78
Circumferential wall thickness measurements of the human left ventricle: reference data for thallium-201 single-photon emission computed tomography. Am J Cardiol (1986) 0.78
Localized beta dosimetry of 131I-labeled antibodies in follicular lymphoma. Med Phys (1992) 0.78
Synthesis and radioiodination of tyramine cellobiose for labeling monoclonal antibodies. Int J Rad Appl Instrum B (1988) 0.78
In vitro and in situ magnetic resonance imaging signal features of atherosclerotic plaque-associated lipids. Arterioscler Thromb Vasc Biol (1997) 0.78
Artifacts in camera based single photon emission tomography due to time activity variation. Eur J Nucl Med (1987) 0.77
High dose radiolabeled antibody therapy of lymphoma. Cancer Res (1990) 0.77
Absolute measurement of total-body calcium by the Ar-37 method-preliminary results: concise communication. J Nucl Med (1977) 0.77
Positron emission tomography: imaging tumor response. Eur J Nucl Med (2000) 0.77
Regional blood-to-tissue transport in an irradiated rat glioma model. Radiat Res (1987) 0.77
Simplified detection system for neuroreceptor studies in the human brain. J Nucl Med (1986) 0.77
Scatter and attenuation correction for 111In based on energy spectrum fitting. Med Phys (1996) 0.76
Assessment of [11C]-L-methionine transport into the human brain. J Cereb Blood Flow Metab (1988) 0.75
The advantage of protecting the antigen-binding site during antibody labeling. J Nucl Med (1991) 0.75
Expanding SimSET to include block detectors: performance with pseudo-blocks and a true block model. IEEE Nucl Sci Symp Conf Rec (1997) (2007) 0.75
A comparison of normalization effects on three whole-body cylindrical 3D PET systems. Phys Med Biol (2000) 0.75
FPGA-Based Pulse Pile-Up Correction With Energy and Timing Recovery. IEEE Trans Nucl Sci (2012) 0.75
Standardized tests of PET performance. J Nucl Med (1992) 0.75
Clinical cone-beam SPECT. J Nucl Med (1994) 0.75
Short-axis circumferential profiles of the heart in healthy subjects: comparison of T1-201 SPECT and two-dimensional echocardiography. Radiology (1988) 0.75
Preliminary observations on excretion of 37Ar from man following whole-body neutron activation--an indicator of total-body calcium. J Nucl Med (1975) 0.75
Estimation of bladder wall absorbed dose. J Nucl Med (1986) 0.75
Absorbed fractions for dose calculations of neuroreceptor PET studies. Eur J Nucl Med (1985) 0.75
On estimating the loss of quantification in PET due to finite detector resolution. Eur J Nucl Med (1987) 0.75
Concerning strategies for in vivo measurement of receptor binding using positron emission tomography. II. J Cereb Blood Flow Metab (1987) 0.75
A simple instrument for biochemical studies of the living human brain. Med Instrum (1987) 0.75
Distance-weighted backprojection: a SPECT reconstruction technique. Radiology (1986) 0.75
Quantification of human caudate d2 dopamine receptor density with positron emission tomography: a review of the model. IEEE Trans Med Imaging (1987) 0.75
Quantitation of bone mass in osteoporosis: recent advances. Calcif Tissue Res (1976) 0.75